Alembic Pharmaceuticals Q2 Results Live: Profit Rise by 12.33% YOY
1 month, 2 weeks ago

Alembic Pharmaceuticals Q2 Results Live: Profit Rise by 12.33% YOY

Live Mint  

Alembic Pharmaceuticals Q2 Results Live : Alembic Pharmaceuticals declared their Q2 results on 07 Nov, 2024, reporting a topline increase of 3.33% and a profit rise of 12.33% year-over-year. Operating income saw a significant jump, up by 8.24% quarter-over-quarter and an impressive 29.09% year-over-year, indicating strong operational efficiency despite rising expenses. In terms of stock performance, Alembic Pharmaceuticals has faced a -4.34% return in the last week, although it boasts a 7.84% return over the past six months and a remarkable 42.2% year-to-date return. Alembic Pharmaceuticals Financials Period Q2 Q1 Q-o-Q Growth Q2 Y-o-Y Growth Total Revenue 1647.98 1561.73 +5.52% 1594.93 +3.33% Selling/ General/ Admin Expenses Total 391.47 379.77 +3.08% 346.99 +12.82% Depreciation/ Amortization 70.51 69.04 +2.13% 67.56 +4.37% Total Operating Expense 1466.36 1393.94 +5.2% 1454.24 +0.83% Operating Income 181.62 167.79 +8.24% 140.69 +29.09% Net Income Before Taxes 180.42 157.03 +14.9% 135.15 +33.5% Net Income 153.4 134.37 +14.16% 136.56 +12.33% Diluted Normalized EPS 7.24 6.84 +5.78% 6.95 +4.1%

Pharmaceuticals Growth Q2 Alembic  total  alembic  pharmaceuticals  income  growth  q2  yoy  results  rise  1233  strong  profit  expenses  yearoveryear  live  increase

History of this topic

Stocks to watch today:
2 weeks, 1 day ago

Stocks to watch today:

India Today  

The Indian stock market ended last week on a flat note despite gains in the auto and FMCG sectors. The Reserve Bank of India’s Monetary Policy Committee decision to maintain the key interest rates for the 11th consecutive time led to subdued trading activity. In today’s session, several stocks, including Ultratech, Paytm, L&T, Biocon, Alembic Pharma, and CEAT, will be …

Glenmark Pharmaceuticals Q2 results 2024 on 16 Nov, 2024: profit at ₹354.21Cr, Revenue increased by 7.06% YoY
1 month, 1 week ago

Glenmark Pharmaceuticals Q2 results 2024 on 16 Nov, 2024: profit at ₹354.21Cr, Revenue increased by 7.06% YoY

Live Mint  

Glenmark Pharmaceuticals Q2 Results 2024:Glenmark Pharmaceuticals declared its Q2 results on 14 Nov, 2024, reporting a significant turnaround with a profit of ₹354.21 crore. As of 16 Nov, 2024, Glenmark Pharmaceuticals has a market cap of ₹43,279.2 crore, with a 52-week high of ₹1,830.95 and a low of ₹746.55. The consensus recommendation among analysts as of 16 Nov, 2024, is …

Astrazeneca Pharma India Q2 Results 2024 on 15 Nov, 2024: profit falls by 26.62% YOY, profit at ₹38.43 crore and revenue at ₹408 crore
Trending News
1 month, 1 week ago

Astrazeneca Pharma India Q2 Results 2024 on 15 Nov, 2024: profit falls by 26.62% YOY, profit at ₹38.43 crore and revenue at ₹408 crore

Live Mint  

Astrazeneca Pharma India Q2 Results 2024:Astrazeneca Pharma India declared its Q2 results for 2024 on November 13, revealing a significant increase in revenue but a decline in profit compared to the previous year. In comparison to the previous quarter, Astrazeneca Pharma India saw a revenue growth of 5.28% and a remarkable profit increase of 425.95%. In terms of stock performance, …

Glenmark Pharma Q2 Results: Pharma major posts net profit of ₹354.48 crore, revenue up 7.5% YoY
1 month, 1 week ago

Glenmark Pharma Q2 Results: Pharma major posts net profit of ₹354.48 crore, revenue up 7.5% YoY

Live Mint  

Glenmark Pharma Q2 Results: Glenmark Pharmaceuticals Limited announced its July to September quarter results on Thursday, November 14. The company posted a ₹354.48 crore net profit in the second quarter of the financial year 2024-25. Glenmark Pharma posted a net loss of ₹180.29 crore in the same quarter the previous year, according to the company's BSE filing on Thursday. Glenmark …

Thermax Q2 Results 2024: Profit Rises by 24.92% YOY
1 month, 1 week ago

Thermax Q2 Results 2024: Profit Rises by 24.92% YOY

Live Mint  

Thermax Q2 Results 2024:Thermax declared their Q2 results on 13 Nov, 2024, showcasing a robust performance with a topline increase of 13.43% year-over-year. As of 14 Nov, 2024, out of 19 analysts covering Thermax, the ratings are mixed, with 1 analyst giving a Strong Sell rating, 8 analysts suggesting Sell, 6 analysts recommending Hold, while 2 analysts have issued Buy …

AstraZeneca Q2 net profit declines 27%, revenue up 31%
1 month, 1 week ago

AstraZeneca Q2 net profit declines 27%, revenue up 31%

Live Mint  

Mumbai: AstraZeneca Pharma India Ltd posted a profit after tax of ₹38 crore, down 27% year-on-year, in the September quarter of FY25. The company’s revenue growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments, Bhavana Agrawal, chief financial officer of the company, said in a release on Wednesday. Palivizumab, also known by the …

Suven Pharmaceuticals Q2 Results Live: Profit Rise by 3.33% YOY
1 month, 1 week ago

Suven Pharmaceuticals Q2 Results Live: Profit Rise by 3.33% YOY

Live Mint  

Suven Pharmaceuticals Q2 Results Live : Suven Pharmaceuticals declared their Q2 results on 12 Nov, 2024, showcasing a robust performance with a topline increase of 11.54% year-over-year. In comparison to the previous quarter, Suven Pharmaceuticals reported an impressive revenue growth of 11.72% along with a significant profit increase of 35.28%. As of 13 Nov, 2024, all analysts covering the company …

Natco Pharma Q2 Results Live: Profit Rises by 83.55% YoY
1 month, 1 week ago

Natco Pharma Q2 Results Live: Profit Rises by 83.55% YoY

Live Mint  

Natco Pharma Q2 Results Live : Natco Pharma announced its Q2 results on November 12, 2024, revealing a significant growth in both topline and profit. In terms of stock performance, Natco Pharma experienced a -2.19% return over the past week; however, the company has delivered a robust 40.5% return in the last six months and an impressive 71.42% year-to-date return. …

Hindalco Industries Q2 Results Live: Profit Rises by 78.01% YOY
Trending News
1 month, 1 week ago

Hindalco Industries Q2 Results Live: Profit Rises by 78.01% YOY

Live Mint  

Hindalco Industries Q2 Results Live : Hindalco Industries declared its Q2 results on November 11, 2024, showcasing a robust performance with revenue increasing by 7.45% year-over-year and a remarkable profit surge of 78.01%. In terms of operating income, Hindalco reported a 2.95% increase compared to the previous quarter and a substantial 43% rise year-over-year, reflecting effective management and operational efficiency. …

JB Chemicals & Pharmaceuticals Q2 Results Live: Profit Rise by 15.92% YOY
1 month, 2 weeks ago

JB Chemicals & Pharmaceuticals Q2 Results Live: Profit Rise by 15.92% YOY

Live Mint  

JB Chemicals & Pharmaceuticals Q2 Results Live : JB Chemicals & Pharmaceuticals has announced its Q2 results for the fiscal year, revealing a notable increase in profits and revenue. The company declared its financial performance on November 6, 2024, showing a year-over-year revenue growth of 13.48% and a profit increase of 15.92%. Despite the mixed results, JB Chemicals & Pharmaceuticals …

Aurobindo Pharma Q1 Results: Net profit rises 61.3% to ₹918 crore, revenue up 10.5% YoY
4 months, 2 weeks ago

Aurobindo Pharma Q1 Results: Net profit rises 61.3% to ₹918 crore, revenue up 10.5% YoY

Live Mint  

Aurobindo Pharma Q1 Results: Aurobindo Pharma released its April-June quarter results for fiscal 2024-25 on August 10, reporting a rise of 61.3 per cent in net profit at ₹918 crore, compared to ₹569 crore in the corresponding period last year. The pharma major's revenue from operations during the first quarter of current fiscal stood at ₹7,567 crore, registering a rise …

Sun Pharma Q1 net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY
1 year, 4 months ago

Sun Pharma Q1 net profit falls 2% to ₹2,022 crore; revenue rises 11% YoY

Live Mint  

Sun Pharmaceutical Industries Ltd on Thursday reported a net profit of ₹2,022.54 crore for the quarter ended June 2023, down 1.86% from ₹2,060.88 crore in the same period last year. Taro posted Q1FY24 sales of $159 million, up by 1.4% YoY and reported net profit of about $10 million, lower by 28.9% over net profit of Q1 last year. “Excluding …

Gland Pharma Q4 net profit declines 72% year-on-year
1 year, 7 months ago

Gland Pharma Q4 net profit declines 72% year-on-year

Live Mint  

The generic injectable focused pharmaceutical company, Gland Pharma Ltd’s reported net profits at ₹78.68 Crore during Q4, saw a sharp decline of 72% over ₹285.90 Crore reported in the year-ago quarter. The India market that accounted for 8% of total revenues during Q4FY23 and witnessed a 68% year-on-year decline is sales which the company attributed to higher base of COVID …

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter
2 years, 8 months ago

Q4 Results Preview: Margins of Pharma companies likely to remain under pressure in the March quarter

Live Mint  

The Indian pharmaceuticals sector has been under pressure from the ongoing Russia-Ukraine war as a majority of pharma companies have a strong presence in both countries. The report estimates EBITDA in 4QFY22E to be sequentially lower for the majority of Indian generic pharma companies on account of lower gross margins due to an increase in raw material costs and sustained …

Aurobindo Pharma shares surge on Q2 earnings
4 years, 1 month ago

Aurobindo Pharma shares surge on Q2 earnings

Live Mint  

Shares of Aurobindo Pharma surged as much as 7% today after the company reported a 26% increase in consolidated net profit in the second quarter ended September. Aurobindo Pharma on Wednesday reported a 26% increase in consolidated net profit at ₹805.65 crore in the second quarter ended September. The company had posted a consolidated net profit of ₹639.53 crore in …

Discover Related